Ping Peng
Academic / Other · 1 registered clinical trial — 1 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Not Yet Recruiting | Orlistat Overcoming Third-generation EGFR-TKI Resistance Lung Adenocarcinoma, Osimertinib | Phase 2 | 2025-02-16 |
Academic / Other · 1 registered clinical trial — 1 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Not Yet Recruiting | Orlistat Overcoming Third-generation EGFR-TKI Resistance Lung Adenocarcinoma, Osimertinib | Phase 2 | 2025-02-16 |